Insider Cluster (2 insiders) ·Filed Aug 25, 2026

TEVA

TEVA PHARMACEUTICAL INDUSTRIES LTD
NEUTRAL
Impact 2/10
Horizonimmediate Processed1mo ago
Insider cluster: 2 insiders, $696K total
Actionable Insight • Neutral

Insider sales at this scale are routine and carry no signal for Teva's stock. The EVP's sale is likely liquidity-driven (vesting or tax planning). Monitor for any 10b5-1 plan disclosures or upcoming earnings/catalyst events that could provide context, but no action warranted from this filing alone.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
TEVA ▲ +2.39% at T+20d
NEUTRAL call ✓ call won +2.39% · α vs SPY +1.41% · entry $38.10 → $39.01
Next anchor: T+60d in 7w
Latest observation: T+25 +6.00% FF3 residual α
Entry anchored
Aug 24, 06:29 PM ET
via 1-min bar
T+1d
-0.47%
call -0.47% · α -0.49%
$37.92
settled 5w ago
T+5d
-4.99%
call -4.99% · α -4.46%
$36.20
settled 5w ago
T+20d
+2.39%
call +2.39% · α +1.41%
$39.01
settled 10d ago
T+60d
—
call — · α —
—
in 7w

Price Chart

Loading chart...

Executive Summary

Two Teva insiders — a director and an EVP — sold a combined $696K in open-market sales over a one-week window. The EVP's $680K sale is the dominant trade; the director's $15K sale is de minimis. At a $43B market cap, the total represents ~0.0016% of market cap, well below the 0.1% materiality floor, making this cluster economically trivial and non-informative.

Key Financial Metrics

Direction
selling
Total Value
$696.0K
Insiders
2

Key Facts

  • EVP Evan Lippman sold 18,600 shares at $36.57 for $680K on 2026-08-17
  • Director Ronit Satchi-Fainaro sold 415 shares at $37.25 for $15K on 2026-08-21
  • Total cluster value of $696K represents ~0.0016% of Teva's $43B market cap
  • No insider buying in the cluster — net direction is selling

Financial Impact

$696K total insider sales, negligible relative to $43B market cap

insider holdings

Risk Factors

  • No material risk identified from this cluster — dollar amounts are trivial
  • If future insider sales accelerate above 0.1% of market cap, that would warrant attention

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-TEVA-1787728399162
31 reports for TEVA
Performance horizon
100% Hit rate 9 of 9 directional calls best @ T+20▲ +17.61%Jul 20, 2026
Filters
Rows
Reports for TEVA — sortable, filterable
TypeNow
Sep 10, 2026
22d ago
Press Release
NEUTRAL ★ 5/10
$36.35 $39.19▲ +7.81%▲ +8.31%$39.29 (+8.09%)
Sep 8, 2026
24d ago
424B5
NEUTRAL ★ 5/10
$36.76 $39.25▲ +6.77%▲ +7.89%$39.29 (+6.88%)
Sep 2, 2026
4w ago
Court Ruling
NEUTRAL ★ 1/10
$37.49 $36.35▼ −3.04%▼ −2.08%$39.29 (+4.80%)
Aug 28, 2026
5w ago
Press Release
BULLISH ★ 6/10
$36.44 $36.36▼ −0.22%▼ −0.33%$39.29 (+7.82%)
Aug 25, 2026
5w ago
Court Ruling
NEUTRAL ★ 2/10
$38.10 $36.20▼ −4.99%▼ −4.46%$39.29 (+3.12%)
Aug 25, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$38.10 $36.20▼ −4.99%▼ −4.46%$39.29 (+3.12%)
Aug 10, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$36.14 $36.46▲ +0.89%▲ +0.93%$39.29 (+8.72%)
Aug 5, 2026
8w ago
Insider Cluster
NEUTRAL ★ 2/10
$34.81 $36.45▲ +4.70%▲ +3.49%$39.29 (+12.87%)
Jul 31, 2026
9w ago
Court Ruling
BULLISH ★ 7/10
$35.01 $35.36▲ +1.00%▼ −2.51%$39.29 (+12.23%)
Jul 29, 2026
9w ago
8-K
MIXED ★ 5/10
$34.71 $34.72▲ +0.03%▼ −5.50%$39.29 (+13.20%)
Showing 10 of 31

US Market Status

Market Open — Closes in 3h 40m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Aug 26, 2026